ImmuCell

(NASDAQ) ICCC

Current Price$8.73

Market Cap$78.98M

Since IPO (1992)+773%

5 Year-20%

1 Year+64%

1 Month+37%

ImmuCell Financials at a Glance

Market Cap

$78.98M

Revenue (TTM)

$27.64M

Net Income (TTM)

$1.04M

EPS (TTM)

$-0.11

P/E Ratio

-76.78

Dividend

$0.00

Beta (Volatility)

0.23 (Low)

Dividend

$0.00

Beta (Volatility)

0.23 (Low)

Price

$8.73

Volume

18,043.014

Open

$8.48

Price

$8.73

Volume

18,043.014

Open

$8.48

Previous Close

$8.73

Daily Range

$8.46 - $8.82

52-Week Range

$4.52 - $8.82

Dividend

$0.00

Beta (Volatility)

0.23 (Low)

Price

$8.73

Volume

18,043.014

Open

$8.48

Previous Close

$8.73

Daily Range

$8.46 - $8.82

52-Week Range

$4.52 - $8.82

ICCC News

ImmuCell Q2 Profit Jumps as Margins Rise

Motley Fool Markets TeamAug 15, 2025

ImmuCell Posts 18% Gain in Q2

Motley Fool Markets TeamAug 14, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ImmuCell

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Olivier te Boekhorst

Website

www.immucell.com

Headquarters

Portland, ME 04103, US

ICCC Financials

Key Financial Metrics (TTM)

Gross Margin

41%

Operating Margin

Net Income Margin

-4%

Return on Equity

-4%

Return on Capital

Return on Assets

-2%

Earnings Yield

-1.30%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$78.98M

Shares Outstanding

9.05M

Volume

18.04K

Avg. Volume

18.29K

Financials (TTM)

Gross Profit

$11.45M

Operating Income

$1.65M

EBITDA

$4.43M

Operating Cash Flow

$2.48M

Capital Expenditure

$1.25M

Free Cash Flow

$1.22M

Cash & ST Invst.

$3.81M

Total Debt

$13.19M

ImmuCell Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$7.63M

-1.6%

Gross Profit

$2.91M

+2.8%

Gross Margin

38.16%

N/A

Market Cap

$78.98M

N/A

Market Cap/Employee

$1.14M

N/A

Employees

N/A

Net Income

$2.85M

-653.7%

EBITDA

$652.00K

-50.6%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$9.39M

+17.2%

Accounts Receivable

$3.42M

-10.3%

Inventory

$9.27M

+30.3%

Long Term Debt

$11.50M

-12.7%

Short Term Debt

$1.70M

-12.1%

Return on Assets

-2.44%

N/A

Return on Invested Capital

4.28%

N/A

Free Cash Flow

$310.24K

+255.7%

Operating Cash Flow

$482.54K

+15915.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CUECue Biopharma, Inc.

CUECue Biopharma, Inc.$30.42+106.38%

FBIOFortress Biotech, Inc.

FBIOFortress Biotech, Inc.$2.33+1.30%

EQEquillium, Inc.

EQEquillium, Inc.$2.08+1.96%

COEPCoeptis Therapeutics, Inc.

COEPCoeptis Therapeutics, Inc.$16.40+0.00%

NRXPNRx Pharmaceuticals, Inc.

NRXPNRx Pharmaceuticals, Inc.$3.09+3.69%

SNTISenti Biosciences, Inc.

SNTISenti Biosciences, Inc.$1.02+10.28%

GNTAGenenta Science S.p.A.

GNTAGenenta Science S.p.A.$0.73+2.64%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

FFord Motor Company

FFord Motor Company$11.88-0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$11.84+0.01%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$44.47+0.03%

Questions About ICCC

What is the current price of ImmuCell?

ImmuCell is trading at $8.73 per share.

What is the 52-week range for ImmuCell?

Over the past 52 weeks, ImmuCell has traded between $4.52 and $8.82.

How much debt does ImmuCell have?

As of the most recent reporting period, ImmuCell reported total debt of $13.19M.

How much cash does ImmuCell have on hand?

ImmuCell reported $3.81M in cash and cash equivalents in its most recent financial results.

What is ImmuCell’s dividend yield?

ImmuCell does not currently have a dividend yield.

ImmuCell

ImmuCell Financials at a Glance

ICCC News

ImmuCell Q2 Profit Jumps as Margins Rise

ImmuCell Posts 18% Gain in Q2

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About ImmuCell

ICCC Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

ImmuCell Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ICCC

What is the current price of ImmuCell?

What is the 52-week range for ImmuCell?

How much debt does ImmuCell have?

How much cash does ImmuCell have on hand?

What is ImmuCell’s dividend yield?

Premium Investing Services